SciELO - Scientific Electronic Library Online

 
vol.139 issue4Remission of vitiligo during treatment with intravenous immunoglobulin: Report of one caseInternational policies towards sick leave: A referent to analyze the Chilean situation author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Revista médica de Chile

Print version ISSN 0034-9887

Abstract

VEGA, Jorge; GOECKE, Helmuth  and  SANTAMARINA, Mario. Retroperitoneal fibrosis associated with chronic use of ergotamine: Report of one case. Rev. méd. Chile [online]. 2011, vol.139, n.4, pp.489-494. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872011000400012.

Retroperitoneal fibrosis (RPF) associated with chronic use of ergotamine is a very rare disorder. We report a 45-year-old woman who presented with a RPf after using, almost daily for 23 years, ergotamine tartrate for migraine relief. FRP presented as a chronicinflammatory state, anemia, abdominal and lumbosacral pain and a hypogastric mass. A CT-Scan showed a periaortic mass and left hydronephrosis. A percutaneous biopsy was obtained and the patient was subjected to a surgical ureterolysis and tissue resection. The biopsy confirmed the presence of RPf. Due to persistent symptoms and increase in the volume of periaortic tissue, treatment with colchicine 1 mg/day and defazacort 30 mg/day was started, resulting in a rapid di-sappearance of symptoms, disappearance ofinflammation and a significant reduction in the volume of the periaortic tissue. The patient remains in complete remission after 29 months of follow up.

Keywords : Anti inflammatory agents; Colchicine; Ergotamine; Retroperitoneal fibrosis.

        · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License